Updated results from the enfortumab vedotin phase 1 (EV-101) study in patients with metastatic urothelial cancer (mUC) Meeting Abstract
| Authors: | Rosenberg, J. E.; Sridhar, S. S.; Zhang, J.; Smith, D. C.; Ruether, J. D.; Flaig, T. W.; Baranda, J. C.; Lang, J. M.; Plimack, E. R.; Sangha, R. S.; Heath, E. I.; Merchan, J. R.; Quinn, D. I.; Srinivas, S.; Milowsky, M. I.; Wu, C.; Gartner, E. M.; Melhem-Bertrandt, A.; Petrylak, D. P. |
| Abstract Title: | Updated results from the enfortumab vedotin phase 1 (EV-101) study in patients with metastatic urothelial cancer (mUC) |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 242s |
| Language: | English |
| ACCESSION: | WOS:000442916002031 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.4504 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 4504 -- Source: Wos |
